Systemic delivery of targeted nanotherapeutic reverses angiotensin II-induced abdominal aortic aneurysms in mice
Abstract Abdominal aortic aneurysm (AAA) disease causes dilation of the aorta, leading to aortic rupture and death if not treated early. It is the 14th leading cause of death in the U.S. and 10th leading cause of death in men over age 55, affecting thousands of patients. Despite the prevalence of AA...
Main Authors: | Xiaoying Wang, Vaideesh Parasaram, Saphala Dhital, Nasim Nosoudi, Shahd Hasanain, Brooks A. Lane, Susan M. Lessner, John F. Eberth, Naren R. Vyavahare |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-04-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-88017-w |
Similar Items
-
Author Correction: Systemic delivery of targeted nanotherapeutic reverses angiotensin II‑induced abdominal aortic aneurysms in mice
by: Xiaoying Wang, et al.
Published: (2021-07-01) -
Nanoparticle-based targeted delivery of pentagalloyl glucose reverses elastase-induced abdominal aortic aneurysm and restores aorta to the healthy state in mice.
by: Saphala Dhital, et al.
Published: (2020-01-01) -
Targeted delivery of pentagalloyl glucose inhibits matrix metalloproteinase activity and preserves elastin in emphysematous lungs
by: Vaideesh Parasaram, et al.
Published: (2021-09-01) -
C-JUN N-TERMINAL KINASE INHIBITORY NANOTHERAPEUTICS FOR REGENERATIVE ELASTIC MATRIX REPAIR IN ABDOMINAL AORTIC ANEURYSMS
by: Camardo, Andrew T.
Published: (2017) -
Evaluation of endovascular repair of abdominal aortic aneurysms
by: Nasim, Akhtar
Published: (1997)